| Issue | Title | |
| No 1 (2021) | От главного редактора | Abstract PDF (Rus) |
| No 2 (2015) | A multifactorial algorithm to predict on-clopidogrel platelet reactivity as a potential way to improve the efficacy and safety of antiplatelet therapy | Abstract PDF (Rus) |
| N. P. Kurcheva, K. B. Mirzaev, D. A. Sychev | ||
| No 1 (2021) | ADRB2 gene polymorphism and preterm labor | Abstract PDF (Rus) |
| R. E. Kazakov, R. A. Chilova, K. O. Akopov, E. A. Sokova | ||
| No 2 (2016) | Antiplatelet therapy with clopidogrel in patients with atherosclerosis of lower limb arteries and diabetes type 2: problems and perspectives of pharmacogenetic approach | Abstract PDF (Rus) |
| M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, A. G. Avtandilov | ||
| No 2 (2015) | Arterial hypertension: molecular-genetic and pharmacogenetic approaches | Abstract PDF (Rus) |
| N. V. Kokh, A. A. Slepukhina, G. I. Lifshits | ||
| No 2 (2015) | Association of gene polymorphisms of eNOS and AGTR2 with the debut of ischemic heart disease: stable and unstable angina, myocardial infarction | Abstract PDF (Rus) |
| A. L. Khokhlov, N. O. Pozdnyakov, A. E. Miroshnikov, D. P. Komarov, I. N. Tsaryova, I. S. Mogutova | ||
| No 2 (2018) | Associations of CYP3A4*22 polymorphism with phenazepam's safety in patients with alcohol withdrawal syndrome | Abstract PDF (Rus) |
| D. V. Ivashchenko, O. V. Tereshchenko, V. V. Smirnov, K. A. Ryzhikova, Zh. A. Sozaeva, Yu. A. Pimenova, E. A. Grishina, M. S. Zastrozhin, L. M. Savchenko, E. A. Bryun, D. A. Sychev | ||
| No 2 (2025) | Choosing a pharmacogenomic strategy for targeted therapy of cystic fibrosis: the story of one patient | Abstract PDF (Rus) |
| A. V. Vlasova, E. E. Yakushina, I. R. Gaziev, O. I. Simonova, U. V. Lukash, D. A. Sychev | ||
| No 1 (2020) | Clinical pharmacogenetics of angiotensin II receptor blockers | Abstract PDF (Rus) |
| I. I. Sinitsina, A. V. Boyarko, I. I. Temirbulatov | ||
| No 2 (2016) | Clinical pharmacogenetics of ticagrelor: is there prospect? | Abstract PDF (Rus) |
| D. A. Sychev, E. S. Torbenkov | ||
| No 2 (2016) | Comparative analysis of cytochrome P450 isoform CYP2C9 in elderly and senile patients with that in healthy volunteers of the first period of middle age | Abstract PDF (Rus) |
| D. A. Sychev, S. P. Bordovsky, V. E. Nikulin, N. I. Polshina, G. S. Anikin, K. S. Danilina, V. V. Smirnov, V. A. Otdelenov | ||
| No 1 (2023) | Comparative study of the CYP2C19, CYP2C9, CYP4F2 gene polymorphisms impact on the clinical and laboratory characteristics of acute coronary syndrome patients | Abstract PDF (Rus) |
| B. I. Kantemirova, M. A. Abdullaev, E. N. Chernysheva, I. Z. Kitiashvili, Z. V. Zharkov, A. N. Romanova, E. R. Konovalova | ||
| No 2 (2016) | Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, SLCO1B1 gene polymorphism frequency in Russian and Nanai populations | Abstract PDF (Rus) |
| G. N. Shuev, D. A. Sychev, S. Sh. Suleymanov, K. A. Ryzhikova, K. B. Mirzaev, E. A. Grishina, N. E. Snalina, Zh. A. Sozaeva, E. S. Il’ina, A. M. Grabuzdov, I. A. Matsneva | ||
| No 1 (2025) | Correlation between CYP2C9 polymorphisms and office blood pressure levels in patients treated with irbesartan and valsartan | Abstract PDF (Rus) |
| E. V. Rebrova, E. V. Shikh | ||
| No 1 (2019) | Corrigendum to the article Zagorodnikova KA, Rustanovich YuG, Kostyuchek DF, Murzina AA. The frequency of polymorphism rs776746 in the CYP3A5 gene in women with non-developing pregnancy. Pharmacogenetics and pharmacogenomics. 2018(1):27-30. | Abstract PDF (Rus) |
| article Editorial | ||
| No 2 (2015) | Cough and angioedema from angiotensin-converting enzyme inhibitors: genetic markers | Abstract PDF (Rus) |
| I. S. Dantsev, I. I. Sinitsina, D. A. Sychev | ||
| No 2 (2024) | Cough associated with angiotensin-converting enzyme inhibitors: the role of pharmacogenetics | Abstract PDF (Rus) |
| M. V. Leonova | ||
| No 1 (2024) | Effect of ATIC, ADA, ITPA, and AMPD1 gene polymorphisms on the efficacy of methotrexate in rheumatoid arthritis | Abstract PDF (Rus) |
| I. V. Devald, E. A. Khodus, K. Yu. Myslivtsova, E. B. Khromova, G. L. Ignatova, A. M. Lila, D. S. Stashkevich | ||
| No 2 (2015) | Effect of polymorphisms in the CYP2C9 gene on valproic acid levels in the blood of women’s in a reproductive age with epilepsy | Abstract PDF (Rus) |
| N. A. Schnayder, D. V. Dmitrenko, Y. B. Govorina, A. V. Muraveva, J. V. Kotlovsky, E. N. Bochanova, E. A. Fateeva, N. A. Dedyuk, A. V. Mustafayeva | ||
| No 1 (2015) | Ethnic differences in the distribution of allele and genotype frequencies for polymorphic markers rs1801275 gene IL-4R, associated with the development of drug allergy in the application of β-lactam antibiotics | Abstract PDF (Rus) |
| I. V. Groznova, K. V. Mirzaev, R. E. Kazakov, D. M. Gafurov, S. N. Mammayev, D. A. Sychev | ||
| No 2 (2015) | Evidence pharmacogenetics: is it possible? | Abstract PDF (Rus) |
| D. A. Sychev | ||
| No 1 (2025) | Falls in elderly patients and their association with genetic factors | Abstract PDF (Rus) |
| V. A. Shalygin, M. I. Savelyeva, I. I. Sinitsina, E. S. Ilyina, M. S. Chernyaeva, D. A. Sychev | ||
| No 1 (2024) | Features of aggregometry indicators in male residents of the Stavropol Territory — representatives of the Russian and Armenian ethnic groups receiving hospital treatment | Abstract PDF (Rus) |
| V. A. Baturin, A. V. Ivanova, A. A. Tsarukyan, K. A. Muravyov | ||
| No 1 (2022) | First phase of antipsychotic metabolism in the liver: the role of oxidation | Abstract PDF (Rus) |
| N. A. Shnayder, A. K. Khasanova, R. F. Nasyrova | ||
| No 1 (2018) | From pharmacogenomics to pharmaco-transcriptomics for real clinical practice | Abstract PDF (Rus) |
| D. A. Sychev | ||
| No 1 (2022) | Genetic and physiological factors predisposing to individual selective serotonine reuptake inhibitors exposure during pregnancy and breast feeding | Abstract PDF (Rus) |
| K. A. Zagorodnikova, S. Yu. Novikova | ||
| No 1 (2018) | Genetic background vitamin D deficiency and modern methods of its correction in children | Abstract PDF (Rus) |
| E. M. Zelenskaya, G. I. Lifshits | ||
| No 2 (2024) | Genetic factors contributing to the development of metabolic syndrome | Abstract PDF (Rus) |
| C. E. Kalashnikova, E. V. Shrayner, V. I. Bystrova, G. I. Lifshits | ||
| No 1 (2015) | Genetic, pathophysiological and clinical aspects of antiplatelet therapy (review) | Abstract PDF (Rus) |
| E. M. Zelenskaya, A. A. Slepuhina, N. V. Koch, K. A. Apartsyn, G. I. Lifshits | ||
| No 2 (2024) | Genetic polymorphisms affect the metabolism of antituberculosis drugs | Abstract PDF (Rus) |
| T. E. Tyulkova, A. P. Tkachuk, K. A. Akmalova, Sh. P. Abdullayev, K. B. Mirzaev, D. A. Sychev, V. A. Manuylov | ||
| 1 - 30 of 256 Items | 1 2 3 4 5 6 7 8 9 > >> | |
Browse Title Index
НАШИ КНИГИ
Другие журналы
"Издательства ОКИ"
ПАРТНЕРЫ
Popular articles
No 1 (2018)
Keywords
ABCB1
CYP2C19
CYP2C9
CYP2D6
CYP3A5
SLCO1B1
clopidogrel
personalized medicine
pharmacogenetics
pharmacogenomics
pharmacokinetics
polymorphism
генотипирование
клопидогрел
острый коронарный синдром
полиморфизм генов
рак молочной железы
фармакогенетика
фармакогенетическое тестирование
шизофрения
эпилепсия
115522, Moscow, Russian Federation, Moskvorechye str. 4-5-129
LLC "Izdatelstvo OKI"
Tel. +7(910) 449-22-73
Email: eva88@list.ru
